{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:47:52Z","timestamp":1782190072350,"version":"3.54.5"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2701103"],"award-info":[{"award-number":["2021YFC2701103"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019230","name":"Wuhan Union Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2024AFB655"],"award-info":[{"award-number":["2024AFB655"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020717","name":"Center for High Performance Computing, Shanghai Jiao Tong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972667"],"award-info":[{"award-number":["81972667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473175"],"award-info":[{"award-number":["82473175"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072736"],"award-info":[{"award-number":["82072736"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472752"],"award-info":[{"award-number":["82472752"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biomaterials.2026.124062","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:01:23Z","timestamp":1770739283000},"page":"124062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PANoptosis-triggering GA-based biomimetic nano-prodrug remodels the tumor microenvironment to enhance antitumor immunity"],"prefix":"10.1016","volume":"330","author":[{"given":"Feiyang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guopei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9779-6225","authenticated-orcid":false,"given":"Jianfeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib1","article-title":"Exploration of the antitumor effect and mechanism of gambogic acid on osteosarcoma through network pharmacology and experimental pharmacology study","volume":"15","author":"Hu","year":"2025","journal-title":"Sci. Rep."},{"issue":"3-4","key":"10.1016\/j.biomaterials.2026.124062_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.lfs.2008.05.003","article-title":"Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells","volume":"83","author":"Chen","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.biomaterials.2026.124062_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155400","article-title":"Discovery of Gambogic acid as an antibacterial adjuvant against vancomycin-resistant enterococci in vitro and in vivo","volume":"128","author":"Pang","year":"2024","journal-title":"Phytomedicine : international journal of phytotherapy and phytopharmacology"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124062_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41419-019-1360-4","article-title":"Gambogic acid triggers vacuolization-associated cell death in cancer cells via disruption of thiol proteostasis","volume":"10","author":"Seo","year":"2019","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124062_bib5","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1182\/blood-2007-03-079616","article-title":"Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-Induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway","volume":"110","author":"Pandey","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib6","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1038\/s41467-024-51980-9","article-title":"AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer","volume":"15","author":"Ouyang","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124062_bib7","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1039\/D3RA08042K","article-title":"Emerging tendencies for the nano-delivery of gambogic acid: a promising approach in oncotherapy","volume":"14","author":"Fahmy","year":"2024","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2024.2361169","article-title":"Advances in cell membrane-based biomimetic nanodelivery systems for natural products","volume":"31","author":"Zhang","year":"2024","journal-title":"Drug Deliv."},{"issue":"31","key":"10.1016\/j.biomaterials.2026.124062_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202401950","article-title":"Simplified gambogic acid prodrug nanoparticles to improve efficiency and reduce toxicity for clinical translation potential","volume":"13","author":"Wang","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2026.124062_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2017.12.014","article-title":"Therapeutic potential of gambogic acid, a caged xanthone, to target cancer","volume":"416","author":"Banik","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2026.124062_bib11","doi-asserted-by":"crossref","first-page":"10385","DOI":"10.2147\/IJN.S277645","article-title":"Gambogic acid as a candidate for cancer therapy: a review","volume":"15","author":"Liu","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biomaterials.2026.124062_bib12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.actbio.2017.08.036","article-title":"Inclusion complex from cyclodextrin-grafted hyaluronic acid and pseudo protein as biodegradable nano-delivery vehicle for gambogic acid","volume":"62","author":"Ji","year":"2017","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib13","first-page":"79","article-title":"Phase\u2160human tolerability trial of gambogic acid","volume":"16","author":"Zhou","year":"2007","journal-title":"Chin. J. New Drugs"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124062_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/bjc.2013.752","article-title":"Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-\u03baB and MAPK\/HO-1 signalling","volume":"110","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124062_bib15","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1021\/acs.nanolett.3c01235","article-title":"PEGylated gambogic acid nanoparticles enable efficient renal-targeted treatment of Acute kidney injury","volume":"23","author":"Li","year":"2023","journal-title":"Nano Lett."},{"issue":"29","key":"10.1016\/j.biomaterials.2026.124062_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202400502","article-title":"Dual-targeted novel temozolomide nanocapsules encapsulating siPKM2 inhibit aerobic glycolysis to sensitize glioblastoma to chemotherapy","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124062_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202412707","article-title":"Dual cascade-responsive multifunctional nanoparticles to overcome bacterium-induced drug inactivation and enhanced photodynamic and chemo-immunotherapy of pancreatic cancer","volume":"21","author":"Li","year":"2025","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12951-024-02425-4","article-title":"GSH-responsive degradable nanodrug for glucose metabolism intervention and induction of ferroptosis to enhance magnetothermal anti-tumor therapy","volume":"22","author":"Liao","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124062_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2008.05.009","article-title":"Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives","volume":"130","author":"Xu","year":"2008","journal-title":"J. Contr. Release : official journal of the Controlled Release Society"},{"key":"10.1016\/j.biomaterials.2026.124062_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144218","article-title":"Glucuronoyl esterases improve cellulose hydrolysis by lignocellulose degrading enzymes and enhance lignin extraction","volume":"314","author":"Martins","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biomaterials.2026.124062_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122789","article-title":"An NIR-responsive hydrogel loaded with polydeoxyribonucleotide nano-vectors for enhanced chronic wound healing","volume":"314","author":"Sun","year":"2025","journal-title":"Biomaterials"},{"issue":"36","key":"10.1016\/j.biomaterials.2026.124062_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202304104","article-title":"Trisulfide bond-mediated molecular phototheranostic platform for \"Activatable\" NIR-II imaging-guided enhanced Gas\/Chemo-Hypothermal photothermal therapy","volume":"10","author":"Wu","year":"2023","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124062_bib23","article-title":"Targeting autophagy plus high-dose CDK4\/6 inhibitors in advanced HR+HER2- breast cancer: a phase 1b\/2 trial","volume":"6","author":"Gong","year":"2025","journal-title":"Med (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41467-025-55905-y","article-title":"Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124062_bib25","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1021\/acsnano.1c00680","article-title":"Targeted noninvasive treatment of choroidal neovascularization by hybrid cell-membrane-cloaked biomimetic nanoparticles","volume":"15","author":"Li","year":"2021","journal-title":"ACS Nano"},{"issue":"30","key":"10.1016\/j.biomaterials.2026.124062_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202001808","article-title":"Engineered cell-membrane-coated nanoparticles directly present tumor antigens to promote anticancer immunity","volume":"32","author":"Jiang","year":"2020","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib27","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1038\/s41467-022-33889-3","article-title":"Systematic design of cell membrane coating to improve tumor targeting of nanoparticles","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124062_bib28","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2147\/IJN.S408521","article-title":"Cancer cell membrane-coated gambogic acid nanoparticles for effective anticancer vaccination by activating dendritic cells","volume":"18","author":"Huang","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124062_bib29","doi-asserted-by":"crossref","first-page":"23746","DOI":"10.1021\/acsnano.3c07555","article-title":"Biomimetic macrophage membrane-camouflaged nanoparticles induce ferroptosis by promoting mitochondrial damage in glioblastoma","volume":"17","author":"Cao","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124062_bib31","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1021\/acs.nanolett.7b05263","article-title":"Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124062_bib32","doi-asserted-by":"crossref","first-page":"11517","DOI":"10.1021\/acsnano.4c16280","article-title":"Engineered cell membrane coating technologies for biomedical applications: from nanoscale to macroscale","volume":"19","author":"An","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124062_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.iy.05.040187.002055","article-title":"Genetically determined murine models of immunodeficiency","volume":"5","author":"Shultz","year":"1987","journal-title":"Annu. Rev. Immunol."},{"issue":"26","key":"10.1016\/j.biomaterials.2026.124062_bib34","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.biomaterials.2026.124062_bib35","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124062_bib36","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S1470-2045(19)30388-2","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study","volume":"20","author":"Robert","year":"2019","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124062_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaoncol.2018.4514","article-title":"Survival outcomes in patients with previously untreated BRAF wild-type advanced melanoma treated with Nivolumab therapy: three-year Follow-up of a randomized phase 3 trial","volume":"5","author":"Ascierto","year":"2019","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124062_bib38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.biomaterials.2026.124062_bib39","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","article-title":"Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"28","author":"Brahmer","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124062_bib40","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1200\/JCO.22.02270","article-title":"Phase I study of single-agent anti-programmed Death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"41","author":"Brahmer","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124062_bib41","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1470-2045(15)00083-2","article-title":"Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial","volume":"16","author":"Ribas","year":"2015","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124062_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.21.02229","article-title":"Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma","volume":"40","author":"Wolchok","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124062_bib43","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1038\/s41591-023-02498-y","article-title":"Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial","volume":"29","author":"VanderWalde","year":"2023","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124062_bib44","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S1470-2045(21)00097-8","article-title":"Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study","volume":"22","author":"Pires da Silva","year":"2021","journal-title":"Lancet Oncol."},{"issue":"26","key":"10.1016\/j.biomaterials.2026.124062_bib45","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124062_bib46","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S1470-2045(18)30700-9","article-title":"Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial","volume":"19","author":"Hodi","year":"2018","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124062_bib47","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124062_bib48","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41590-022-01141-1","article-title":"A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance","volume":"23","author":"Huang","year":"2022","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124062_bib49","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.tcb.2025.01.009","article-title":"Decoding melanoma's cellular mosaic to unlock immunotherapy potential","volume":"35","author":"Pozniak","year":"2025","journal-title":"Trends Cell Biol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124062_bib50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124062_bib51","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41423-025-01329-z","article-title":"PANoptosis in cancer: bridging molecular mechanisms to therapeutic innovations","volume":"22","author":"Lin","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12943-024-02130-8","article-title":"Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124062_bib53","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7150\/thno.91814","article-title":"Current evidence and therapeutic implication of PANoptosis in cancer","volume":"14","author":"Ocansey","year":"2024","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib54","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/imr.13279","article-title":"PANoptosis: mechanisms, biology, and role in disease","volume":"321","author":"Sun","year":"2024","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124062_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202419649","article-title":"Nanomaterials-induced PANoptosis: a promising anti-tumor strategy","volume":"64","author":"Hou","year":"2025","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124062_bib56","doi-asserted-by":"crossref","first-page":"eadq3870","DOI":"10.1126\/sciadv.adq3870","article-title":"Endogenous\/Exogenous dual-responsive nanozyme for photothermally enhanced ferroptosis-immune reciprocal synergistic tumor therapy","volume":"11","author":"Zhang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2026.124062_bib57","article-title":"Lysosomal cathepsin S escape facilitates near infrared light-triggered pyroptosis via an antibody-indocyanine green conjugate","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124062_bib58","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41419-023-06370-2","article-title":"Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib59","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41420-024-01978-5","article-title":"The role of IFI16 in regulating PANoptosis and implication in heart diseases","volume":"10","author":"Chang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biomaterials.2026.124062_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112739","article-title":"IRF1 and IL1A associated with PANoptosis serve as potential immune signatures for lung ischemia reperfusion injury following lung transplantation","volume":"139","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124062_bib61","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.7150\/thno.111635","article-title":"Oxidative stress-mediated PANoptosis and ferroptosis: exploration of multimodal cell death triggered by an AIE-active nano-photosensitizer via photodynamic therapy","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"issue":"45","key":"10.1016\/j.biomaterials.2026.124062_bib62","doi-asserted-by":"crossref","first-page":"eadp7160","DOI":"10.1126\/sciadv.adp7160","article-title":"Bimetallic peroxide nanoparticles induce PANoptosis by disrupting ion homeostasis for enhanced immunotherapy","volume":"10","author":"Hou","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40779-025-00629-9","article-title":"Ultrasound initiated tumor catalytic PANoptosis by mesoporous piezoelectric nanocatalysts","volume":"12","author":"Xu","year":"2025","journal-title":"Military Medical Research"},{"issue":"46","key":"10.1016\/j.biomaterials.2026.124062_bib64","doi-asserted-by":"crossref","first-page":"39805","DOI":"10.1021\/acsnano.5c12658","article-title":"Natural macrophage membrane-coated nanoparticles as a multifaceted sepsis therapeutic to sequester inflammatory and toxic mediators","volume":"19","author":"Hoffman","year":"2025","journal-title":"ACS Nano"},{"issue":"735","key":"10.1016\/j.biomaterials.2026.124062_bib65","doi-asserted-by":"crossref","first-page":"eadh9751","DOI":"10.1126\/scitranslmed.adh9751","article-title":"Chondrocyte membrane-coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis","volume":"16","author":"Deng","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124062_bib66","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41568-025-00847-2","article-title":"Advancing engineering design strategies for targeted cancer nanomedicine","volume":"25","author":"Gomerdinger","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124062_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.10.033","article-title":"pH-Sensitive morphological transitions in polymeric tadpole assemblies for programmed tumor therapy","volume":"293","author":"Song","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124062_bib68","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","article-title":"Preparation and application of pH-responsive drug delivery systems","volume":"348","author":"Ding","year":"2022","journal-title":"J. Contr. Release"},{"issue":"37","key":"10.1016\/j.biomaterials.2026.124062_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202300078","article-title":"Three strategies in engineering nanomedicines for tumor microenvironment-enabled phototherapy","volume":"19","author":"He","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124062_bib70","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.colsurfb.2017.08.057","article-title":"Tunable pH and redox-responsive drug release from curcumin conjugated \u03b3-polyglutamic acid nanoparticles in cancer microenvironment","volume":"159","author":"Pillarisetti","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biomaterials.2026.124062_bib71","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.colsurfb.2015.12.040","article-title":"Core-shell microcapsules of solid lipid nanoparticles and mesoporous silica for enhanced oral delivery of curcumin","volume":"140","author":"Kim","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biomaterials.2026.124062_bib72","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.2147\/IJN.S528334","article-title":"Construction of active-passive dual-targeted drug-loaded micelle nanoparticles with modified dopamine molecules for efficient anti-tumor therapy","volume":"20","author":"Chen","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124062_bib73","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1021\/acsnano.1c11040","article-title":"pH\/Glucose dual responsive metformin release Hydrogel dressings with adhesion and self-healing via dual-dynamic bonding for athletic diabetic foot wound healing","volume":"16","author":"Liang","year":"2022","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124062_bib74","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.1021\/acs.nanolett.0c02622","article-title":"Tailored chemodynamic nanomedicine improves pancreatic cancer treatment via controllable damaging neoplastic cells and reprogramming tumor microenvironment","volume":"20","author":"Chen","year":"2020","journal-title":"Nano Lett."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124062_bib75","doi-asserted-by":"crossref","first-page":"14494","DOI":"10.1021\/acsnano.3c01019","article-title":"Janus Silica nanoparticle-based tumor microenvironment modulator for restoring tumor sensitivity to programmed cell death ligand 1 immune checkpoint blockade therapy","volume":"17","author":"Lin","year":"2023","journal-title":"ACS Nano"},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124062_bib76","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1016\/j.biomaterials.2012.02.059","article-title":"The accumulation of dual pH and temperature responsive micelles in tumors","volume":"33","author":"Chen","year":"2012","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124062_bib77","doi-asserted-by":"crossref","first-page":"11492","DOI":"10.1021\/acsnano.3c01369","article-title":"Tumor-Generated reactive oxygen species storm for high-performance ferroptosis therapy","volume":"17","author":"Huang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124062_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116695","article-title":"Gambogic acid induces GSDME dependent pyroptotic signaling pathway via ROS\/P53\/Mitochondria\/Caspase-3 in ovarian cancer cells","volume":"232","author":"Zhang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biomaterials.2026.124062_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155657","article-title":"Gambogic acid exhibits promising anticancer activity by inhibiting the pentose phosphate pathway in lung cancer mouse model","volume":"129","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib80","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13046-024-03089-6","article-title":"Cell death shapes cancer immunity: spotlighting PANoptosis","volume":"43","author":"Gao","year":"2024","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124062_bib81","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41401-024-01376-8","article-title":"Baicalin inhibits PANoptosis by blocking mitochondrial Z-DNA formation and ZBP1-PANoptosome assembly in macrophages","volume":"46","author":"You","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124062_bib82","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.040334","article-title":"Circ-myh8\/KAT7 affects PANoptosis in pulmonary arterial smooth muscle cells: involvement of super-enhancers in FOSL2 expression","volume":"14","author":"Zhang","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biomaterials.2026.124062_bib83","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.freeradbiomed.2025.07.037","article-title":"Porcine epidemic diarrhea virus induces PANoptosis in piglet intestinal cells via Z-RNA\/ZBP1\/ROS pathway-mediated oxidative stress activation","volume":"239","author":"Sun","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124062_bib84","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124062_bib85","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124062_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102351","article-title":"Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma","volume":"54","author":"Xu","year":"2022","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124062_bib87","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.tips.2023.02.003","article-title":"Recent advances in targeting autophagy in cancer","volume":"44","author":"Jain","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124062_bib88","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124062_bib89","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41580-020-0241-0","article-title":"Mechanisms governing autophagosome biogenesis","volume":"21","author":"Nakatogawa","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124062_bib90","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41580-021-00392-4","article-title":"Machinery, regulation and pathophysiological implications of autophagosome maturation","volume":"22","author":"Zhao","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124062_bib91","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41419-020-03162-w","article-title":"PDK4 promotes vascular calcification by interfering with autophagic activity and metabolic reprogramming","volume":"11","author":"Ma","year":"2020","journal-title":"Cell Death Dis."},{"issue":"27","key":"10.1016\/j.biomaterials.2026.124062_bib92","article-title":"Synergistic lysosomal impairment and ER stress activation for boosted autophagy dysfunction based on Te double-headed nano-bullets","volume":"18","author":"Wang","year":"2022","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib93","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41467-018-03225-9","article-title":"Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22141","article-title":"Mechanism of gambogic acid repressing invasion and metastasis of colorectal cancer by regulating macrophage polarization via tumor cell-derived extracellular vesicle-shuttled miR-21","volume":"85","author":"Li","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124062_bib95","article-title":"ROS-Driven nanoventilator for MRSA-Induced acute lung injury treatment via in situ oxygen supply, anti-inflammation and immunomodulation","volume":"12","author":"Luo","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.biomaterials.2026.124062_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218037","article-title":"Oncoprotein SND1-enriched exosomes facilitate melanoma lung metastasis by regulating CD47-SIRP\u03b1-mediated macrophage reprogramming","volume":"634","author":"Chen","year":"2025","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib97","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jre.13196","article-title":"Interleukin-37 ameliorates periodontitis development by inhibiting NLRP3 inflammasome activation and modulating M1\/M2 macrophage polarization","volume":"59","author":"Yang","year":"2024","journal-title":"J. Periodontal. Res."},{"key":"10.1016\/j.biomaterials.2026.124062_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123605","article-title":"Temporary silk nanocoatings preserve immune cell functions and protection against biochemical and mechanical stressors","volume":"325","author":"Kumarasinghe","year":"2026","journal-title":"Biomaterials"},{"issue":"45","key":"10.1016\/j.biomaterials.2026.124062_bib99","article-title":"Ccl2-Induced regulatory T cells balance inflammation through macrophage polarization during liver reconstitution","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"Pt 2","key":"10.1016\/j.biomaterials.2026.124062_bib100","article-title":"Bionic sulfated glycosaminoglycan-based hydrogel inspired by snail mucus promotes diabetic chronic wound healing via regulating macrophage polarization","volume":"281","author":"Sun","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124062_bib101","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.immuni.2023.07.018","article-title":"Targeting innate immune pathways for cancer immunotherapy","volume":"56","author":"Cao","year":"2023","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124062_bib102","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/annonc\/mdl158","article-title":"Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients","volume":"18","author":"Parmiani","year":"2007","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124062_bib103","first-page":"301","article-title":"Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma","volume":"19","author":"Deichmann","year":"2000","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124062_bib104","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00262-008-0644-9","article-title":"Human interleukin 10 receptor 1\/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential","volume":"58","author":"Terai","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"issue":"17","key":"10.1016\/j.biomaterials.2026.124062_bib105","article-title":"Optimization of lipid nanoparticles with robust efficiency for the delivery of protein therapeutics to augment cancer immunotherapy","volume":"12","author":"Ren","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"31","key":"10.1016\/j.biomaterials.2026.124062_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202309583","article-title":"Multiple treatment of triple-negative breast cancer through gambogic acid-loaded mesoporous polydopamine","volume":"20","author":"Liu","year":"2024","journal-title":"Small"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124062_bib107","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.7150\/ijbs.5033","article-title":"Insights on FoxN1 biological significance and usages of the \"nude\" mouse in studies of T-lymphopoiesis","volume":"8","author":"Zhang","year":"2012","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124062_bib108","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1084\/jem.181.3.1223","article-title":"Transgenic expression of interleukin 7 restores T cell populations in nude mice","volume":"181","author":"Rich","year":"1995","journal-title":"J. Exp. Med."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124062_bib109","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1039\/D2CS00099G","article-title":"Degradable polyprodrugs: design and therapeutic efficiency","volume":"51","author":"Seidi","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124062_bib110","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202213578","article-title":"An Antitumor dual-responsive host-guest supramolecular polymer based on hypoxia-cleavable Azocalix[4]arene","volume":"62","author":"Yao","year":"2023","journal-title":"Angew. Chem."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124062_bib111","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1021\/acsnano.4c17291","article-title":"Starfish-Inspired synergistic reinforced hydrogel wound dressing: dual responsiveness and enhanced bioactive compound delivery for advanced skin regeneration and management","volume":"19","author":"Hong","year":"2025","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124062_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202407245","article-title":"Less is more: biomimetic hybrid membrane nanocarriers for highly efficient tumor targeted drug delivery","volume":"21","author":"Chen","year":"2025","journal-title":"Small"},{"issue":"28","key":"10.1016\/j.biomaterials.2026.124062_bib113","doi-asserted-by":"crossref","first-page":"25072","DOI":"10.1021\/jacs.5c09121","article-title":"Self-Propulsion of biomimetic nanomotors promotes diffusion and convection transport for enhanced radiotherapy in solid glioblastoma","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2026.124062_bib114","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.actbio.2023.11.029","article-title":"Cell membrane-based biomimetic technology for cancer phototherapy: mechanisms, recent advances and perspectives","volume":"174","author":"Li","year":"2024","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib115","article-title":"Recent advances in cell membrane-camouflaged nanoparticles for cancer phototherapy","volume":"15","author":"Zhen","year":"2019","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib116","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124062_bib117","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.7150\/thno.108875","article-title":"Macrophage membrane-functionalized nanotherapeutics for tumor targeted therapy","volume":"15","author":"Khan","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib118","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124062_bib119","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.apsb.2022.02.023","article-title":"Cell membrane coated-nanoparticles for cancer immunotherapy","volume":"12","author":"Zeng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.apsb.2017.11.009","article-title":"Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment","volume":"8","author":"Li","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124062_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103514","article-title":"Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy","volume":"28","author":"Huang","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biomaterials.2026.124062_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-025-01329-z","article-title":"PANoptosis in cancer: bridging molecular mechanisms to therapeutic innovations","author":"Lin","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124062_bib123","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.cell.2023.05.005","article-title":"NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs","volume":"186","author":"Sundaram","year":"2023","journal-title":"Cell"},{"issue":"7876","key":"10.1016\/j.biomaterials.2026.124062_bib124","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","article-title":"AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence","volume":"597","author":"Lee","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124062_bib125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cytogfr.2024.03.005","article-title":"Z-DNA binding protein 1 orchestrates innate immunity and inflammatory cell death","volume":"77","author":"Song","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biomaterials.2026.124062_bib126","article-title":"The emerging role of PANoptosis in cancer treatment","volume":"168","author":"Xiong","year":"2023","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.biomaterials.2026.124062_bib127","article-title":"Advances in mechanism and regulation of PANoptosis: prospects in disease treatment","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."},{"issue":"5-6","key":"10.1016\/j.biomaterials.2026.124062_bib128","first-page":"681","article-title":"Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma, Apoptosis","volume":"29","author":"Jiang","year":"2024","journal-title":"an international journal on programmed cell death"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124062_bib129","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10142-023-01003-5","article-title":"Molecular subtypes based on PANoptosis-related genes and tumor microenvironment infiltration characteristics in lower-grade glioma","volume":"23","author":"Abulaiti","year":"2023","journal-title":"Funct. Integr. Genom."},{"key":"10.1016\/j.biomaterials.2026.124062_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109019","article-title":"Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer","volume":"238","author":"Pan","year":"2022","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124062_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202006484","article-title":"Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy","volume":"17","author":"Oroojalian","year":"2021","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124062_bib132","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41565-024-01618-0","article-title":"Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles","volume":"19","author":"Li","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124062_bib133","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12951-020-00649-8","article-title":"Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy","volume":"18","author":"Gong","year":"2020","journal-title":"J. Nanobiotechnol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226000864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226000864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:09:41Z","timestamp":1782187781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226000864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":133,"alternative-id":["S0142961226000864"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124062","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PANoptosis-triggering GA-based biomimetic nano-prodrug remodels the tumor microenvironment to enhance antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124062"}}